Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endmic area of Ecuador

Saved in:
Bibliographic Details
Published inVaccine Vol. 12; no. 4; pp. 337 - 342
Main Authors SEMPERTEGUI, F, ESTRELLA, B, CORDOVA, M. E, SUAREZ, J, ZICKER, F, MOSCOSO, J, PIEDRAHITA C, L, HERNANDEZ, D, GAYBOR, J, BARANJO, P, MANCERO, O, ARIAS, S, BERNAL, R
Format Journal Article
LanguageEnglish
Published Oxford Elsevier 1994
Subjects
Biological and medical sciences
Human protozoal diseases
Infectious diseases
Malaria
Medical sciences
Parasitic diseases
Protozoal diseases
South America
Ecuador
America
Human
Immunoprotection
Protozoa
Protozoal disease
Immune response
Malaria
Vaccine
Harmlessness
Infection
Plasmodium falciparum
Synthetic product
Immunogenicity
Placebo
Double blind study
Sporozoa
Online AccessGet full text

Cover

More Information
ISSN:0264-410X
1873-2518